About RHÖN-KLINIKUM Aktiengesellschaft (RHK)
RHÖN-KLINIKUM Aktiengesellschaft is a Medical Care Facilities company operating in the Healthcare sector. The company is headquartered in Bad Neustadt an der Saale, Germany. RHK has been publicly traded since 1998, giving it 28+ years of trading history.
RHÖN-KLINIKUM Aktiengesellschaft (RHK) has been publicly traded since 1998, making it a 28-year-old public company. It operates in the Medical Care Facilities industry within the Healthcare sector. The company is headquartered in Bad Neustadt an der Saale, Germany and employs approximately 19,041 people. With a market capitalization of €850 million, RHK is a smaller company with higher growth potential.
RHK trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a small-cap-cap stock with a market capitalization of approximately €850 million. The company employs approximately 19,041 people worldwide.
Key Statistics
- Current Price
- €12.70
- Market Cap
- €850.12M
- 52-Week High
- €16.40
- 52-Week Low
- €11.20
- Sector
- Healthcare
- Industry
- Medical Care Facilities
RHK Investment Performance
RHK has declined 0.0% year-to-date in 2026. Over the past 5 years, a €1,000 investment in RHK would have grown to €827, representing a -17.4% total return. Since its IPO in 1998, a €1,000 investment would now be worth €5,151.
€1,000 Invested in RHÖN-KLINIKUM Aktiengesellschaft (RHK)
How much would €1,000 invested in RHK be worth today?
What would €1,000 invested in RHK 1 year ago be worth today?
A €1,000 investment in RHÖN-KLINIKUM Aktiengesellschaft (RHK) in 2025 would be worth €1,000 as of March 2026, representing a +0.0% total return.
What would €1,000 invested in RHK 3 years ago be worth today?
A €1,000 investment in RHÖN-KLINIKUM Aktiengesellschaft (RHK) in 2023 would be worth €1,012 as of March 2026, representing a +1.2% total return.
What would €1,000 invested in RHK 5 years ago be worth today?
A €1,000 investment in RHÖN-KLINIKUM Aktiengesellschaft (RHK) in 2021 would be worth €827 as of March 2026, representing a -17.4% total return.
What would €1,000 invested in RHK 10 years ago be worth today?
A €1,000 investment in RHÖN-KLINIKUM Aktiengesellschaft (RHK) in 2016 would be worth €505 as of March 2026, representing a -49.5% total return.
What would €1,000 invested in RHK at IPO be worth today?
A €1,000 investment in RHÖN-KLINIKUM Aktiengesellschaft (RHK) at IPO would be worth €5,151 as of March 2026, representing a +415.1% total return.
Monthly Returns Heatmap
Over the past 27+ years (328 months), RHÖN-KLINIKUM Aktiengesellschaft (RHK) has averaged a monthly return of +0.86% with a median return of +0.65%. The stock had 174 positive months (53%) and 149 negative months (45%). The best month in RHK's history was July 2007 with a +88.6% return, while the worst was December 2002 at -21.5%. Historically, April tends to be the strongest month (averaging +5.9%), and May the weakest (-1.0%).
RHK's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 5 consecutive months of losses. The best full year was 2007 with a cumulative return of +114.0%, and the worst was 2002 at -49.9%.
Annual Returns
Over 28 years of trading history, RHÖN-KLINIKUM Aktiengesellschaft (RHK) has delivered an average annual return of +10.68% with a median return of +6.15%. The compound annual growth rate (CAGR) is +6.10%. The stock posted gains in 17 years (61%) and losses in 11 years (39%).
RHK's best year was 2007 with a +140.12% gain, while the worst was 2002 at -44.52%. The longest streak of consecutive positive years was 5, and the longest losing streak was 4 years. RHK achieved double-digit gains (10%+) in 11 years. It suffered double-digit losses in 6 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +0.00% | €12.70 | €12.70 |
| 2025 | -7.88% | €13.79 | €12.70 |
| 2024 | +39.00% | €9.92 | €13.79 |
| 2023 | -33.86% | €15.00 | €9.92 |
| 2022 | +6.40% | €14.09 | €15.00 |
| 2021 | -12.85% | €16.17 | €14.09 |
| 2020 | -5.61% | €17.13 | €16.17 |
| 2019 | -19.86% | €21.38 | €17.13 |
| 2018 | -25.56% | €28.72 | €21.38 |
| 2017 | +17.98% | €24.34 | €28.72 |
| 2016 | -4.46% | €25.48 | €24.34 |
| 2015 | +23.23% | €20.68 | €25.48 |
| 2014 | +10.24% | €18.76 | €20.68 |
| 2013 | +40.88% | €13.31 | €18.76 |
| 2012 | +6.23% | €12.53 | €13.31 |
| 2011 | -8.62% | €13.72 | €12.53 |
| 2010 | -2.19% | €14.02 | €13.72 |
| 2009 | +6.07% | €13.22 | €14.02 |
| 2008 | -19.80% | €16.48 | €13.22 |
| 2007 | +140.12% | €6.86 | €16.48 |
| 2006 | +17.81% | €5.83 | €6.86 |
| 2005 | +49.87% | €3.89 | €5.83 |
| 2004 | +8.74% | €3.58 | €3.89 |
| 2003 | +53.41% | €2.33 | €3.58 |
| 2002 | -44.52% | €4.20 | €2.33 |
| 2001 | +0.27% | €4.19 | €4.20 |
| 2000 | +21.89% | €3.44 | €4.19 |
| 1999 | +42.15% | €2.42 | €3.44 |
RHK Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating RHÖN-KLINIKUM Aktiengesellschaft as an investment
Valuation
RHK currently trades at a trailing P/E ratio of 22.3, which is considered moderate relative to the broader market. The forward P/E of 16.7 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 0.6. The price-to-sales ratio is 0.4.
Dividends
RHÖN-KLINIKUM Aktiengesellschaft pays a dividend to shareholders with a current yield of 0.79%. This translates to €0.10 per share annually. The payout ratio of 18% indicates sustainable dividend coverage.
Risk & Volatility
RHK has a beta of -0.05, indicating it is less volatile than the overall market. The stock's 52-week range is €11.20 to €16.40, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 1 analyst opinion, RHK has a consensus "hold" rating. The average price target of €12.50 suggests 1.6% downside from current levels.
Frequently Asked Questions: RHK
What sector is RHK in? ▼
RHK operates in the Healthcare sector, specifically in the Medical Care Facilities industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has RHK performed historically? ▼
Over 28 years of trading history, RHK has posted gains in 17 years (61% of the time). The best year was 2007 with a +140.1% return. Past performance does not guarantee future results.
How can I invest in RHK? ▼
You can invest in RHK through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold RHK.
Does RHK pay dividends? ▼
RHÖN-KLINIKUM Aktiengesellschaft pays a dividend to shareholders with a current yield of 0.79%. This translates to €0.10 per share annually. The payout ratio of 18% indicates sustainable dividend coverage.
What does RHÖN-KLINIKUM Aktiengesellschaft do? ▼
RHÖN-KLINIKUM Aktiengesellschaft is a Medical Care Facilities company operating in the Healthcare sector. The company is headquartered in Bad Neustadt an der Saale, Germany.
What sector is RHK in? ▼
RHK operates in the Healthcare sector, specifically in the Medical Care Facilities industry.
When did RHK go public? ▼
RHÖN-KLINIKUM Aktiengesellschaft went public in 1998, making it a 28-year-old public company as of 2026.
How much would €1,000 invested in RHK 5 years ago be worth today? ▼
A €1,000 investment in RHK five years ago would be worth approximately €827 today, representing a -17.4% return.
How much would €1,000 invested in RHK 10 years ago be worth today? ▼
A €1,000 investment in RHK ten years ago would be worth approximately €505 today, representing a -49.5% total return over the decade.
What is RHK's 3-year return? ▼
Over the past 3 years, RHK has returned 1.2%. A €1,000 investment would have grown to €1,012.
How much would €1,000 invested in RHK at IPO be worth today? ▼
If you invested €1,000 in RHK at its IPO in 1998, it would be worth approximately €5,151 today, a 415.1% return over 28 years.
Does RHK pay dividends? ▼
Yes, RHÖN-KLINIKUM Aktiengesellschaft pays a dividend with a current yield of 0.79%, which is €0.1 per share annually.
What is RHK's market cap? ▼
RHÖN-KLINIKUM Aktiengesellschaft has a market capitalization of €850 million, classifying it as a small-cap company.
What is RHK's P/E ratio? ▼
RHK has a trailing P/E ratio of 22.3 and a forward P/E of 16.7, which measures how much investors are paying per dollar of earnings.
Is RHK a buy, hold, or sell? ▼
Based on 1 opinion, RHK has a consensus "hold" rating. The average price target is €12.5.
Last updated: 3/15/2026